Glycolysis inhibitors as a potential therapeutic option to treat aggressive neuroblastoma expressing GLUT1

Journal of Pediatric Surgery

Volumn 47, Issue 7, 2012, Pages 1323-1330

  Matsushita, Kohei ^a   Uchida, Keiichi ^a   Saigusa, Susumu ^a   Ide, Shozo ^a   Hashimoto, Kiyoshi ^a   Koike, Yuki ^a   Otake, Kohei ^a   Inoue, Mikihiro ^a   Tanaka, Koji ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

GLUT 1; Neuroblastoma; Prognostic marker

Indexed keywords

3 BROMOPYRUVATE ACID; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; GLUCOSE TRANSPORTER 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; GLYCOLYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICRODISSECTION; NEUROBLASTOMA; NEUROBLASTOMA CELL; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TRANSPORTER TYPE 1; HUMANS; INFANT; KI-67 ANTIGEN; MALE; NEUROBLASTOMA; PYRUVATES; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84864122028     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2011.12.007     Document Type: Article

References (32)

1. N. Esiashvili, C. Anderson, and H.M. Katzenstein Neuroblastoma Curr Probl Cancer 33 2009 333 360
2. J.M. Maris, and K.K. Matthay Molecular biology of neuroblastoma J Clin Oncol 17 1999 2264 2279
3. K.J. Isselbacher Sugar and amino acid transport by cells in culture - differences between normal and malignant cells N Engl J Med 286 1972 929 933
4. P.L. Pedersen The cancer cell's power plants as promising therapeutic targets: an overview J Bioenerg Biomembr 39 2007 1 12
5. R.E. Airley, and A. Mobasheri Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics Chemotherapy 53 2007 233 256
6. R.A. Medina, and G.I. Owen Glucose transporters: expression, regulation and cancer Biol Res 35 2002 9 26
7. M. Younes, A. Ertan, and L.V. Lechago Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia Cancer Epidemiol Biomarkers Prev 6 1997 303 305
8. M. Sakashita, N. Aoyama, and R. Minami Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features Eur J Cancer 37 2001 204 209
9. M. Grover-McKay, S.A. Walsh, and E.A. Seftor Role for glucose transporter 1 protein in human breast cancer Pathol Oncol Res 4 1998 115 120
10. A. Godoy, V. Ulloa, and F. Rodriguez Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues J Cell Physiol 207 2006 614 627
11. P.E. North, A. Mizeracki, and M.C. Mihm Jr GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma Clin Neuropathol 19 2000 131 137
12. V.C. Russo, K. Kobayashi, and S. Najdovska Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system Brain Res 1009 2004 40 53
13. J.F. Geschwind, C.S. Georgiades, and Y.H. Ko Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma Expert Rev Anticancer Ther 4 2004 449 457
14. Y.H. Ko, P.L. Pedersen, and J.F. Geschwind Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase Cancer Lett 173 2001 83 91
15. T. Scholzen, and J. Gerdes The Ki-67 protein: from the known and the unknown J Cell Physiol 182 2000 311 322
16. R. Yerushalmi, R. Woods, and P.M. Ravdin Ki67 in breast cancer: prognostic and predictive potential Lancet Oncol 11 2010 174 183
17. M.X. Lin, Z.F. Wen, and Z.Y. Feng Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues Ai Zheng 27 2008 1321 1326
18. Y. Sanada, S. Osada, and Y. Tokuyama Critical role of c-Met and Ki67 in progress of biliary carcinoma Am Surg 76 2010 372 379
19. P. Rudolph, T. Lappe, and B. Hero Prognostic significance of the proliferative activity in neuroblastoma Am J Pathol 150 1997 133 145
20. M. del Carmen Mejia, S. Navarro, and A. Pellin Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors Arch Med Res 33 2002 466 472
21. S. Saigusa, Y. Toiyama, and K. Tanaka Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy Ann Surg Oncol 17 2010 2051 2058
22. K.E. Bijwaard, N.S. Aguilera, and Y. Monczak Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma Clin Chem 47 2001 195 201
23. A.C. Clavo, R.S. Brown, and R.L. Wahl Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia J Nucl Med 36 1995 1625 1632
24. M. Younes, L.V. Lechago, and J.R. Somoano Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers Cancer Res 56 1996 1164 1167
25. B.Y. Fang, and J.P. Jia Human neuroblastoma cells transfected with two Chinese presenilin 1 mutations are sensitized to trophic factor withdrawal and protected by insulin-like growth factor-1 Chin Med J (Engl) 121 2008 910 915
26. R.J. Shaw Glucose metabolism and cancer Curr Opin Cell Biol 18 2006 598 608
27. S. Matoba, J.G. Kang, and W.D. Patino p53 regulates mitochondrial respiration Science 312 2006 1650 1653
28. C. Munoz-Pinedo, C. Ruiz-Ruiz, and C. Ruiz de Almodovar Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing J Biol Chem 278 2003 12759 12768
29. D.S. Izyumov, A.V. Avetisyan, and O.Y. Pletjushkina Wages of fear: transient threefold decrease in intracellular ATP level imposes apoptosis Biochim Biophys Acta 1658 2004 141 147
30. R.H. Xu, H. Pelicano, and Y. Zhou Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia Cancer Res 65 2005 613 621
31. D. Singh, A.K. Banerji, and B.S. Dwarakanath Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme Strahlenther Onkol 181 2005 507 514
32. Y.H. Ko, B.L. Smith, and Y. Wang Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP Biochem Biophys Res Commun 324 2004 269 275